摘要
目的探究芪归四逆散联合恩替卡韦治疗乙型肝炎的临床疗效。方法选取我院2013年8月—2015年4月收治的74例乙型肝炎患者,依据治疗方法分组,各37例。单一组予以恩替卡韦治疗,于此基础上,联合组予以芪归四逆散治疗。观察统计两组患者临床效果。结果两组总有效率相比,联合组94.59%明显高于单一组70.27%,差异有统计学意义(P<0.05)。结论对乙型肝炎患者予以芪归四逆散与恩替卡韦联合治疗,疗效较为显著,在临床治疗中具有重要意义。
Objective To explore the clinical effect of Qigui Sini powder combined with entecavir in the treatment of hepatitis B. Methods74 cases of hepatitis B patients treated in our hospital from August 2013 to April 2015 were selected,and thery were divided into groups according to treatment method,with 37 cases in each group. The singel group was given entecavir treatment. On this basis,the combination group was treated with Qigui Sini powder. Clinical effect of two groups was observed and analyzed. Results The total effective rate of the two groups was compared,the combination group（94. 59%） was significantly higher than that of the single group（70. 27%）,and the difference was statistically significant（P 0. 05）. Conclusion Combination therapy with Qigui Sini powder combined with entecavir for patients with hepatitis B,the curative effect is more significant,and has important significance in clinical treatment.
作者
张华平
ZHANG Huaping(Department of Internal Medicine, Xiping County People＇s Hospital, Henan Province, Xiping 463900, Chin)
出处
《光明中医》
2017年第5期657-658,共2页
GUANGMING JOURNAL OF CHINESE MEDICINE
关键词
积聚
芪归四逆散
恩替卡韦
乙型肝炎
Abdominal mass
Qigui Sini powder
Entecavir
Hepatitis B
